In conclusion, therefore, our experiments reveal a novel action of catalytically active MMP-8 in breast cancer cells that results in increased production of key regulators of tumor growth and inflammation, IL-6, and IL-8. This evidence concerns the gene CXCL8 and breast carcinoma.